IRIS Accounts Production v24.3.0.553 04762891 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh047628912023-03-31047628912024-03-31047628912023-04-012024-03-31047628912022-03-31047628912022-04-012023-03-31047628912023-03-3104762891ns15:EnglandWales2023-04-012024-03-3104762891ns14:PoundSterling2023-04-012024-03-3104762891ns10:Director12023-04-012024-03-3104762891ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3104762891ns10:SmallEntities2023-04-012024-03-3104762891ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104762891ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104762891ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104762891ns10:FullAccounts2023-04-012024-03-310476289112023-04-012024-03-3104762891ns10:OrdinaryShareClass12023-04-012024-03-3104762891ns5:CurrentFinancialInstruments2024-03-3104762891ns5:CurrentFinancialInstruments2023-03-3104762891ns5:ShareCapital2024-03-3104762891ns5:ShareCapital2023-03-3104762891ns5:SharePremium2024-03-3104762891ns5:SharePremium2023-03-3104762891ns5:CapitalRedemptionReserve2024-03-3104762891ns5:CapitalRedemptionReserve2023-03-3104762891ns5:RetainedEarningsAccumulatedLosses2024-03-3104762891ns5:RetainedEarningsAccumulatedLosses2023-03-3104762891ns10:RegisteredOffice2023-04-012024-03-3104762891ns5:PatentsTrademarksLicencesConcessionsSimilar2023-04-012024-03-3104762891ns5:IntangibleAssetsOtherThanGoodwill2023-03-3104762891ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3104762891ns5:IntangibleAssetsOtherThanGoodwill2024-03-3104762891ns5:IntangibleAssetsOtherThanGoodwill2023-03-3104762891ns5:ComputerEquipment2023-03-3104762891ns5:ComputerEquipment2023-04-012024-03-3104762891ns5:ComputerEquipment2024-03-3104762891ns5:ComputerEquipment2023-03-3104762891ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3104762891ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3104762891ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 04762891 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

Proteinlogic Limited

Proteinlogic Limited (Registered number: 04762891)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Proteinlogic Limited (Registered number: 04762891)

Balance Sheet
31 March 2024

2024 2023
Notes £    £    £    £   
Fixed assets
Intangible assets 4 16,635 17,694
Tangible assets 5 102 136
16,737 17,830

Current assets
Debtors 6 228 3,252
Cash at bank 94,425 41,676
94,653 44,928
Creditors: amounts falling due within
one year

7

1,867

4,751
Net current assets 92,786 40,177
Total assets less current liabilities 109,523 58,007

Capital and reserves
Called up share capital 8 1,818 1,818
Share premium 2,582,572 2,582,572
Capital redemption reserve 18,721 18,721
Retained earnings (2,493,588 ) (2,545,104 )
Shareholders' funds 109,523 58,007

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Proteinlogic Limited (Registered number: 04762891)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 September 2024 and were signed on its behalf by:





A Woolfson - Director


Proteinlogic Limited (Registered number: 04762891)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. Statutory information

Proteinlogic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 04762891

Registered office: 50/60 Station Road
Cambridge
CB1 2JH

The presentation currency of the financial statements is in Pound Sterling (£) and rounding is to the nearest (£).

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised over their estimated useful lives of 14 and 18 years.

Tangible fixed assets
Tangible fixed assets are stated at cost or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% reducing balance

Grants receivable
Grants receivable are recognised in the year of receipt.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Proteinlogic Limited (Registered number: 04762891)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

2. Accounting policies - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

3. Employees and directors

The average number of employees during the year was NIL (2023 - NIL).

4. Intangible fixed assets
Other
intangible
assets
£   
Cost
At 1 April 2023
and 31 March 2024 19,110
Amortisation
At 1 April 2023 1,416
Charge for year 1,059
At 31 March 2024 2,475
Net book value
At 31 March 2024 16,635
At 31 March 2023 17,694

Proteinlogic Limited (Registered number: 04762891)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

5. Tangible fixed assets
Computer
equipment
£   
Cost
At 1 April 2023
and 31 March 2024 1,249
Depreciation
At 1 April 2023 1,113
Charge for year 34
At 31 March 2024 1,147
Net book value
At 31 March 2024 102
At 31 March 2023 136

6. Debtors: amounts falling due within one year
2024 2023
£    £   
Other debtors 228 3,252

7. Creditors: amounts falling due within one year
2024 2023
£    £   
Trade creditors - 1,009
Taxation and social security 66 -
Other creditors 1,801 3,742
1,867 4,751

8. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,818 Ordinary 0.01 1,818 1,818